Get to know our clinical trials

Trial to evaluate the safety of GEN1042 in subjects with malignant solid tumors

THE AIM OF THE TRIAL IS TO TEST WHETHER GEN1042 IS USEFUL AGAINST CERTAIN TYPES OF SOLID TUMOR CANCERS

Imagen Dr. Ignacio Melero Bermejo, Inmunología
Dr. Ignacio Melero Bermejo Curriculum
Codirector Immunology and Immunotherapy Department
Navarre headquarters
Cancer Center
Liver and Pancreatic Cancer Area
Status
In recruitment
headquarters
Pamplona/Madrid

Technical Summary

  • FIRST IN-HUMAN, OPEN-LABEL, DOSE-ESCALATION TRIAL WITH EXTENSION COHORTS TO EVALUATE THE SAFETY OF GEN1042 IN SUBJECTS WITH MALIGNANT SOLID TUMORS
  • Code EudraCT: 2018-003716-47
  • Protocol number: GCT1042-01
  • Promoter: Genmab A/S

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs
Read more about this clinical trial
Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION